| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $12.1M | — | +42.9% |
| Cost of Revenue | $4.4M | — | +30.4% |
| Gross Profit | $7.8M | — | +51.1% |
| R&D Expense | $4.5M | — | +33.8% |
| SG&A Expense | $5.0M | — | +22.4% |
| Operating Income | -$8.5M | — | -37.6% |
| Pre-tax Income | -$9.5M | — | -58.9% |
| Income Tax | $8K | — | -55.6% |
| Net Income | -$9.6M | — | -58.5% |
| EPS (Basic) | -$0.32 | — | -45.5% |
| EPS (Diluted) | -$0.32 | — | -45.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $35.6M | -22.5% | +187.3% |
| Accounts Receivable | $8.7M | +32.3% | +137.3% |
| Inventory | $8.6M | +2.6% | +30.2% |
| Current Assets | $54.9M | -13.7% | +126.6% |
| Total Assets | $93.4M | -4.4% | +210.7% |
| Current Liabilities | $9.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.0M | — | -29.1% |
| Capital Expenditures | $645K | — | +252.5% |
| Investing Cash Flow | -$645K | — | -252.5% |
| Financing Cash Flow | -$1.8M | — | -35.5% |
| Free Cash Flow | -$8.6M | — | -35.5% |
| +38.1% |
| Long-term Debt | $49.6M | +1.2% | — |
| Total Liabilities | $74.6M | +7.0% | +639.6% |
| Stockholders' Equity | $18.8M | -32.8% | -5.7% |